The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

By emphasizing analytical studies instead of routine clinical trials, the FDA signals its intent to reduce the cost (often estimated at $100 million to $300 million) and time (typically 6–9 years) ...

Chimpanzees use a variation of the "scientific method" — discarding prior beliefs if convincing new evidence comes along to ...

The schedule gods must enjoy sail-gating, because they did the Huskies (6-2) a solid the next three games. Here's where UW ...

The current Scaffold Law imposes strict liability on contractors, developers, and owners regarding fall from heights injuries ...

A recent review published in Pediatric Physical Therapy has highlighted deficiencies in the scientific support and ...

“I think shame, guilt and worry are the most common disruptors of happiness, just in what I see in working with people,” said ...

Demand forecasting remains one of the most complex challenges in retail management. As consumer behavior evolves rapidly, ...

Fifteen scholars will join the Princeton Presidential Postdoctoral Research Fellows program for its 2025 cohort, from disciplines spanning the humanities, engineering, sciences and social sciences.

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy ...